US EditionCHLA-Led Behavioral Health Team Receives $6.4 Million Research Grant for Clinical Trial on Combined Treatments for Pediatric Anxiety
Summary by Newswise
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
CHLA-Led Behavioral Health Team Receives $6.4 Million Research Grant for Clinical Trial on Combined Treatments for Pediatric Anxiety
The new clinical trial will explore how the antidepressant fluoxetine, a selective serotonin reuptake inhibitor (SSRI) that works by increasing activity of serotonin, the mood-regulating chemical in the brain, can be used on its own or in combination with cognitive behavioral therapy to effectively treat pediatric anxiety. While Dr. Peterson's previous research has shown how these treatments can address anxiety symptoms over a short period, the …
·Charlottesville, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
